All peptides
VIP

VIP

VIP is a real signalling peptide with documented immune functions, and its analogue aviptadil reached randomized trials in COVID-19 associated...

About:

A 28-amino-acid signalling peptide, studied as aviptadil in respiratory failure and in sarcoidosis.

WellnessNasal spray or vial

What does this peptide do?

Backed by human trial data, narrower than the strongest evidence. Research focuses on respiratory failure and sarcoidosis.

Respiratory failure

Studied as aviptadil in respiratory failure.

Sarcoidosis

Also studied in sarcoidosis.

Evidence grade

B

Highest evidence grade among the graded claims: B. Grades reflect study strength, not benefit.

What are the benefits and side effects of this peptide

What research says it may help with

  • VIP is a real signalling peptide with documented immune functions, and its analogue aviptadil reached randomized trials in COVID-19 associated respiratory failure.

Who should avoid it

  • People who are pregnant or breastfeeding
  • Children and adolescents
  • People with low blood pressure, given the vasodilatory action
  • Known hypersensitivity to peptide preparations

See the safety section. Absence of a flag is not evidence of safety.

A grade reflects evidence strength, not a recommendation to use this compound; a strong grade can attach to a harmful effect.

How to store this peptide

Typically sold as a lyophilized powder. Reconstituted solutions are perishable, need refrigeration, and require clean handling to avoid contamination.

Lyophilized storage

Keep refrigerated at 2–8 °C, protected from light.

Reconstituted storage

Once opened, keep refrigerated and use within a short period.

Storage Handling

Do not freeze. Discard if the solution is discoloured or contains particles.

Related research

Related research is coming soon for this peptide.

Related peptides

Save hours, stay ahead, and join the elite 1% who prioritize their wellness with science-backed knowledge in minutes.

By clicking Subscribe, you agree to receive MaxHuman research summaries by email. Unsubscribe anytime.

Trusted by 1,525 readers